Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMP360 in post-traumatic stress disorder
NCT07570654Phase 3Recruiting
- Sponsor
- COMPASS Pathways
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Countries
- 2
01
Overview
A Phase 3 trial of COMP360 in post-traumatic stress disorder (PTSD), sponsored by COMPASS Pathways. Started Sep 2026; status: recruiting.
02
Drugs
COMP360
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07570654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07570654.